COVID Neuro Network: Guillain-Barré Syndrome Cases and Patients on Immunomodulators

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. After a successful first webinar, we will now review the first few cases of Guillain-Barré syndrome (GBS) following SARS-CoV-2 infection and discuss the management of patients on immunomodulators during the COVID-19 pandemic.

This series is brought together by the COVID Neuro Network and the Liverpool Brain Infections Group.

Find out more by visiting: https://braininfectionsglobal.tghn.org

20 June 2020

Видео COVID Neuro Network: Guillain-Barré Syndrome Cases and Patients on Immunomodulators канала The Global Health Network